With the growing wait list of individuals waiting for kidney transplantation, there has been renewed interest in the quality and function of donor organs. In particular, concern about the development of delayed allograft function (DGF) after transplantation continues to lead to the avoidance of donor organs offered to a transplant center. DGF is associated with worse short-and long-term outcomes and associated with higher rejection rates. There are no FDA-approved therapies to mitigate the ischemic injury that occurs. Risk factors include both donor and recipient characteristics, although their prediction is not precise. With new understanding about mechanisms of injury and new focus on the function of the deceased donor, there is opportunity to identify not only novel therapies to improve allograft function but to identify potential biomarkers of DGF. DGF remains a significant factor in impacting kidney transplant outcome, and finding biomarkers will assist in the development and approval of novel agents to ameliorate early and later injury. This mini-review highlights our presentation at the 23rd International Conference on Advances in Critical Care Nephrology and UAB/UCSD O’Brien Center Acute Kidney Injury (AKI) Pre-Meeting.

Keywords:
Acute renal injury, Allograft, Chemokine, Outcomes, Transplantation
1.
Watts RP, Thom O, Fraser JF: Inflammatory signalling associated with brain dead organ donation: from brain injury to brain stem death and posttransplant ischaemia reperfusion injury. J Transplant 2013; 2013: 521369.
2.
Siedlecki A, Irish W, Brennan DC: Delayed graft function in the kidney transplant. Am J Transplant 2011; 11: 2279–2296.
3.
Wang CJ, Wetmore JB, Israni AK: Old versus new: progress in reaching the goals of the new kidney allocation system. Human Immunol 2017; 78: 9–15.
4.
Zens TJ, Danobeitia JS, Leverson G, Chlebeck PJ, Zitur LJ, Redfield RR, et al: The impact of kidney donor profile index on delayed graft function and transplant outcomes: A single-center analysis. Clin Transplant 2018; 32: e13190.
5.
Buchanan P, Schnitzler M, Axelrod D, Salvaggio P: The clinical and financial burden of early dialysis after deceased donor kidney transplantation. J Nephrol Therapeutic 2011;S4: 001.
6.
Rosin DL, Okusa MD: Dangers within: DAMP responses to damage and cell death in kidney disease. J Am Soc Nephrol 2011; 22: 416–425.
7.
Irish WD, Ilsley JN, Schnitzler MA, Feng S, Brennan DC: A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant 2010; 10: 2279–2286.
8.
Hall IE, Yarlagadda SG, Coca SG, Wang Z, Doshi M, Devarajan P, et al: IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol 2010; 21: 189–197.
9.
Reese PP, Hall IE, Weng FL, Schroppel B, Doshi MD, Hasz RD, et al: Associations between deceased-donor urine injury biomarkers and kidney transplant outcomes. J Am Soc Nephrol 2016; 27: 1534–1543.
10.
Pianta TJ, Peake PW, Pickering JW, Kelleher M, Buckley NA, Endre ZH: Evaluation of biomarkers of cell cycle arrest and inflammation in prediction of dialysis or recovery after kidney transplantation. Transpl Int 2015; 28: 1392–1404.
11.
Pianta TJ, Peake PW, Pickering JW, Kelleher M, Buckley NA, Endre ZH: Clusterin in kidney transplantation: novel biomarkers versus serum creatinine for early prediction of delayed graft function. Transplantation 2015; 99: 171–179.
12.
Ho J, Wiebe C, Gibson IW, Hombach-Klonisch S, Gao A, Rigatto C, et al: Elevated urinary CCL2: Cr at 6 months is associated with renal allograft interstitial fibrosis and inflammation at 24 months. Transplantation 2014; 98: 39–46.
13.
Mansour SG, Puthumana J, Reese PP, Hall IE, Doshi MD, Weng FL, et al: Associations between deceased-donor uMCP-1 and kidney transplant outcomes. Kidney Int Rep 2017; 2: 749–758.
14.
Moers C, Smits JM, Maathuis MH, Treckmann J, van Gelder F, Napieralski BP, et al: Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360: 7–19.
15.
Niemann CU, Feiner J, Swain S, Bunting S, Friedman M, Crutchfield M, et al: Therapeutic hypothermia in deceased organ donors and kidney-graft function. N Engl J Med 2015; 373: 405–414.
16.
National Academies of Sciences E, Medicine. Opportunities for Organ Donor Intervention Research: Saving Lives by Improving the Quality and Quantity of Organs for Transplantation. James FC, Sarah D, Catharyn TL, editors. Washington, The National Academies Press, 2017.
17.
Husain SA, Chiles MC, Lee S, Pastan SO, Patzer RE, Tanriover B, et al: Characteristics and performance of unilateral kidney transplants from deceasedd. Clin J Am Soc Nephrol 2018; 13: 118–127.
18.
Nashan B, Abbud-Filho M, Citterio F: Prediction, prevention, and management of delayed graft function: where are we now? Clin Transplant 2016; 30: 1198–1208.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.